K. Klucher

发表

Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic

J. Freeman, Dennis M. Miller, Jeff Meyer, 2013, Journal of clinical and translational hepatology.

In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins

J. T. Kadonaga, D. Spector, M. Sommer, 1993, Molecular and Cellular Biology.

Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses

J. Renauld, G. Kochs, S. Paludan, 2008, PLoS pathogens.

In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins

J. T. Kadonaga, D. Spector, M. Sommer, 1993, Molecular and cellular biology.

Tannin-protein interactions.

A. Hagerman, K. Klucher, 1986, Progress in clinical and biological research.

Stromal-Derived Factor-1? The BCR/ABL Oncogene Alters the Chemotactic Response to

G. Daley, J. Griffin, M. Sattler, 2012 .

The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.

G. Daley, R. Salgia, U. V. von Andrian, 1999, Blood.

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

M. Neurath, H. Lehr, S. Kotenko, 2011, EMBO molecular medicine.

Human cytomegalovirus early gene expression.

D. Spector, D. Rabert, D. Wright, 1990, Current topics in microbiology and immunology.

The AINTEGUMENTA gene of Arabidopsis required for ovule and female gametophyte development is related to the floral homeotic gene APETALA2.

L. Reiser, R. Fischer, K. Klucher, 1996, The Plant cell.

An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus

D. Spector, K. Klucher, E. Wade, 1992, Journal of virology.

The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor

D. Spector, K. Klucher, Kevin M. Klucher, 1990, Journal of virology.

Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver‐Distributed Farnesoid X‐Receptor Agonist TERN‐101 in Healthy Volunteers

Christopher Jones, M. Fenaux, M. Charlton, 2021, Clinical pharmacology in drug development.

Tolerability, humoral immune response, and disease control in phase 1 patients receiving ONT-10, a MUC1 liposomal vaccine.

J. Nemunaitis, K. Klucher, Ned Adams, 2014 .

Abstract 762: ONT-10, a liposomal vaccine targeting hypoglycosylated MUC1, induces a potent cellular and humoral response and suppresses the growth of MUC1 expressing tumors

J. Millard, S. Koppenol, K. Klucher, 2011 .

IL-28, IL-29 and their class II cytokine receptor IL-28R

Scott R. Presnell, Betty Haldeman, Brian Fox, 2002, Nature Immunology.

Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys.

S. Pederson, J. Freeman, K. Byrnes-Blake, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Interferon Lambda as a Potential New Therapeutic for Hepatitis C

J. Freeman, Dennis M. Miller, K. Klucher, 2009, Annals of the New York Academy of Sciences.

Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes

Pallavur Sivakumar, Don Foster, D. Foster, 2006, Hepatology.

Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene

D. Spector, D. Rabert, K. Klucher, 1989, Journal of virology.

An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity1

U. Jensen, H. Haugen, S. Paludan, 2008, The Journal of Immunology.

Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells

J. Hiscott, P. Österlund, I. Julkunen, 2005, Journal of Virology.

Inhibition of Interferon Signaling by the Kaposi's Sarcoma-Associated Herpesvirus Full-Length Viral Interferon Regulatory Factor 2 Protein

A. Davison, C. Cunningham, D. Blackbourn, 2006, Journal of Virology.

Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice

G. Daley, R. Perlingeiro, S. Dessain, 2001, Oncogene.

Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression.

G. Daley, K. Klucher, D. V. Lopez, 1998, Blood.

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

Razelle Kurzrock, David S. Hong, Antonio Jimeno, 2012, Clinical Cancer Research.

A gene encoding a host-specific elicitor protein of Phytophthora parasitica.

S. Kamoun, B. Tyler, M. Coffey, 1993, Molecular plant-microbe interactions : MPMI.

Selective Thyroid Hormone Receptor β Agonists with Oxadiazolone Acid Isosteres.

Christopher Jones, Yingzi Xu, M. Fenaux, 2020, Bioorganic & medicinal chemistry letters.

Phase 1 dose escalation of ONT-10, a therapeutic MUC1 vaccine, in patients with advanced cancer

J. Nemunaitis, C. Bedell, A. Vo, 2013, Journal of Immunotherapy for Cancer.